- Home
- RFM vs ANIX Comparison
RFM vs ANIX Comparison
Compare RFM & ANIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RFM
- ANIX
- Stock Information
- Founded
- RFM 2020
- ANIX 1982
- Country
- RFM United States
- ANIX United States
- Employees
- RFM N/A
- ANIX N/A
- Industry
- RFM Finance/Investors Services
- ANIX Biotechnology: Pharmaceutical Preparations
- Sector
- RFM Finance
- ANIX Health Care
- Exchange
- RFM Nasdaq
- ANIX Nasdaq
- Market Cap
- RFM 92.3M
- ANIX 82.7M
- IPO Year
- RFM N/A
- ANIX 1987
- Fundamental
- Price
- RFM $15.35
- ANIX $2.79
- Analyst Decision
- RFM
- ANIX Strong Buy
- Analyst Count
- RFM 0
- ANIX 2
- Target Price
- RFM N/A
- ANIX $8.50
- AVG Volume (30 Days)
- RFM 20.7K
- ANIX 123.7K
- Earning Date
- RFM 01-01-0001
- ANIX 01-10-2025
- Dividend Yield
- RFM 9.74%
- ANIX N/A
- EPS Growth
- RFM N/A
- ANIX N/A
- EPS
- RFM N/A
- ANIX N/A
- Revenue
- RFM N/A
- ANIX N/A
- Revenue This Year
- RFM N/A
- ANIX N/A
- Revenue Next Year
- RFM N/A
- ANIX N/A
- P/E Ratio
- RFM N/A
- ANIX N/A
- Revenue Growth
- RFM N/A
- ANIX N/A
- 52 Week Low
- RFM $12.89
- ANIX $2.07
- 52 Week High
- RFM $16.41
- ANIX $5.00
- Technical
- Relative Strength Index (RSI)
- RFM 53.96
- ANIX 53.61
- Support Level
- RFM $14.95
- ANIX $2.07
- Resistance Level
- RFM $15.21
- ANIX $2.69
- Average True Range (ATR)
- RFM 0.12
- ANIX 0.19
- MACD
- RFM 0.06
- ANIX 0.05
- Stochastic Oscillator
- RFM 100.00
- ANIX 93.55
About RFM RiverNorth Flexible Municipal Income Fund Inc.
RiverNorth Flexible Municipal Income Fund Inc is a diversified, closed-end management investment company. Its primary investment objective is to seek current income exempt from regular U.S. federal income taxes. The fund's secondary investment objective is total return.
About ANIX Anixa Biosciences Inc.
Anixa Biosciences Inc, a cancer-focused biotechnology company, developing vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.